v3.25.1
Summary of Significant Accounting Policies - Schedule of Disaggregation of Our Revenue (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Disaggregation of Our Revenue [Line Items]      
Total $ 15,864,773 $ 19,433,945 $ 14,151,516
Medical training and education services [Member]      
Schedule of Disaggregation of Our Revenue [Line Items]      
Total 7,704,812 6,385,735 6,604,487
Patient management services in patient-aid projects [Member]      
Schedule of Disaggregation of Our Revenue [Line Items]      
Total 5,910,370 3,998,455 6,288,602
Sales of patented drugs [Member]      
Schedule of Disaggregation of Our Revenue [Line Items]      
Total 2,151,809 9,027,211 1,216,096
Other revenues [Member]      
Schedule of Disaggregation of Our Revenue [Line Items]      
Total $ 97,782 $ 22,544 $ 42,331